SAN FRANCISCO, CA--(Marketwire - May 03, 2011) - Medivation, Inc. (NASDAQ: MDVN) today announced that Gretchen Burke, an executive with more than 25 years of finance and business experience, has joined the company as vice president, finance and business processes.
"We are delighted to welcome a finance officer of Gretchen's caliber to our senior management team," said Patrick Machado, chief business and financial officer of Medivation. "Her proven track record of successfully building and managing finance and business teams and processes in rapid growth environments will be a valuable addition to our company as we move our pipeline candidates through the final stage of clinical development and toward potential commercialization with our partners."
Prior to joining Medivation, Ms. Burke served as vice president, finance integrations at Omniture, Inc., where she helped build a scalable finance and accounting function to support revenue growth from $145 million to $350 million over a two year period, culminating in Omniture's acquisition by Adobe Systems in 2009 for $1.8 billion. Prior to that, Ms. Burke was vice president, finance at VeriSign Inc. Earlier in her career she held finance positions at Accretive Solutions, the San Francisco Food Bank and the Sara Lee Corporation. Ms. Burke earned a B.S. from Indiana University.
About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Astellas and Pfizer, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer and mild-to-moderate Alzheimer's disease. For more information, please visit us at www.medivation.com.
